Also trades as: DTC.CN (CNQ) · $vol 0M
DTCFF OTC
Defence Therapeutics Inc.
1W: -18.9%
1M: -22.8%
3M: -7.5%
YTD: -50.2%
1Y: -45.0%
3Y: -87.1%
5Y: -94.8%
$0.28
+0.00 (+0.83%)
Weekly Expected Move ±10.8%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$3M
+30.0% ▲
Capital Expenditures
$0
+100.0% ▲
Free Cash Flow
-$3M
+33.2% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$1M
+143.0% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$3M | -$7M | -$7M | -$13M | -$4M |
| Depreciation & Amort. | $0 | $0 | $14K | $91K | $72K |
| Stock-Based Comp. | $606K | $371K | $295K | $6M | $0 |
| Change in Working Capital | -$36K | $928K | -$1M | $3M | -$1M |
| Other Non-Cash Items | $678K | $327K | $708K | $398K | $1M |
| Operating Cash Flow | -$2M | -$6M | -$8M | -$4M | -$3M |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | $0 | -$66K | -$203K | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $4K |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | -$66K | -$203K | $4K |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $2M | $27K | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $3M | $0 | -$594K | -$161K | $0 |
| Financing Cash Flow | $6M | $1M | $10M | $2M | $5M |
| Net Change in Cash | $4M | -$5M | $2M | -$3M | $1M |
| Cash End of Period | $5M | $507K | $3M | $57K | $1M |
| Free Cash Flow | -$2M | -$6M | -$8M | -$4M | -$3M |